296 related articles for article (PubMed ID: 26207517)
1. Cocrystal Transition Points: Role of Cocrystal Solubility, Drug Solubility, and Solubilizing Agents.
Lipert MP; Rodríguez-Hornedo N
Mol Pharm; 2015 Oct; 12(10):3535-46. PubMed ID: 26207517
[TBL] [Abstract][Full Text] [Related]
2. Cocrystal Solubilization in Biorelevant Media and its Prediction from Drug Solubilization.
Lipert MP; Roy L; Childs SL; Rodríguez-Hornedo N
J Pharm Sci; 2015 Dec; 104(12):4153-4163. PubMed ID: 26390213
[TBL] [Abstract][Full Text] [Related]
3. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.
Kuminek G; Cao F; Bahia de Oliveira da Rocha A; Gonçalves Cardoso S; Rodríguez-Hornedo N
Adv Drug Deliv Rev; 2016 Jun; 101():143-166. PubMed ID: 27137109
[TBL] [Abstract][Full Text] [Related]
4. Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.
Huang N; Rodríguez-Hornedo N
J Pharm Sci; 2011 Dec; 100(12):5219-34. PubMed ID: 21910122
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Basis of Cocrystal Dissolution Advantage.
Cao F; Amidon GL; Rodríguez-Hornedo N; Amidon GE
J Pharm Sci; 2018 Jan; 107(1):380-389. PubMed ID: 28989017
[TBL] [Abstract][Full Text] [Related]
6. Mitigating Cocrystal Physical Stability Liabilities in Preclinical Formulations.
Bhardwaj S; Lipert M; Bak A
J Pharm Sci; 2017 Jan; 106(1):31-38. PubMed ID: 27665129
[TBL] [Abstract][Full Text] [Related]
7. Cocrystal Solubility Advantage Diagrams as a Means to Control Dissolution, Supersaturation, and Precipitation.
Huang Y; Kuminek G; Roy L; Cavanagh KL; Yin Q; Rodríguez-Hornedo N
Mol Pharm; 2019 Sep; 16(9):3887-3895. PubMed ID: 31318567
[TBL] [Abstract][Full Text] [Related]
8. A novel solubilization technique for poorly soluble drugs through the integration of nanocrystal and cocrystal technologies.
Karashima M; Kimoto K; Yamamoto K; Kojima T; Ikeda Y
Eur J Pharm Biopharm; 2016 Oct; 107():142-50. PubMed ID: 27393561
[TBL] [Abstract][Full Text] [Related]
9. The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation.
Machado TC; Kuminek G; Cardoso SG; Rodríguez-Hornedo N
Eur J Pharm Sci; 2020 Sep; 152():105422. PubMed ID: 32531350
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.
Cavanagh KL; Maheshwari C; Rodríguez-Hornedo N
J Pharm Sci; 2018 Jan; 107(1):113-120. PubMed ID: 29097226
[TBL] [Abstract][Full Text] [Related]
11. Cocrystal Solubility Advantage and Dose/Solubility Ratio Diagrams: A Mechanistic Approach To Selecting Additives and Controlling Dissolution-Supersaturation-Precipitation Behavior.
Cavanagh KL; Kuminek G; Rodríguez-Hornedo N
Mol Pharm; 2020 Nov; 17(11):4286-4301. PubMed ID: 32815731
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.
Panzade PS; Shendarkar GR
Curr Drug Deliv; 2017; 14(8):1097-1105. PubMed ID: 27758692
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
14. Cocrystal dissociation in the presence of water: a general approach for identifying stable cocrystal forms.
Eddleston MD; Madusanka N; Jones W
J Pharm Sci; 2014 Sep; 103(9):2865-2870. PubMed ID: 24824298
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic Analysis of Cocrystal Dissolution as a Function of pH and Micellar Solubilization.
Cao F; Amidon GL; Rodriguez-Hornedo N; Amidon GE
Mol Pharm; 2016 Mar; 13(3):1030-46. PubMed ID: 26877267
[TBL] [Abstract][Full Text] [Related]
16. Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility.
Vasilev NA; Surov AO; Voronin AP; Drozd KV; Perlovich GL
Int J Pharm; 2021 Apr; 599():120441. PubMed ID: 33675927
[TBL] [Abstract][Full Text] [Related]
17. Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals.
Aitipamula S; Das S
Eur J Pharm Biopharm; 2020 Apr; 149():95-104. PubMed ID: 32035236
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical cocrystals and poorly soluble drugs.
Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
[TBL] [Abstract][Full Text] [Related]
19. Cocrystallization for successful drug delivery.
Sun CC
Expert Opin Drug Deliv; 2013 Feb; 10(2):201-13. PubMed ID: 23256822
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the causes of cocrystal dissociation at high humidity.
Eddleston MD; Thakuria R; Aldous BJ; Jones W
J Pharm Sci; 2014 Sep; 103(9):2859-2864. PubMed ID: 24481664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
